Coronavirus Vaccine Prospects

https://blogs.sciencemag.org/pipeline/archives/2020/04/15/coronavirus-vaccine-prospects GSK (bringing the spike protein) and Sanofi (bringing the adjuvant) are going to collaborate on vaccine development. Johnson and Johnson have a stricter timeline planning first-in-human trials in September, while Pfizer with BioNTech is possibly starting human trials in August. The NRDD counts around 78 real vaccine programs, with a diversity of approaches. There … Read more

Shih and Sun, “Specter of possible new virus emerging from central China raises alarms across Asia,” Washington Post, January 8, 2020.

By this point in January, it was clear to some observers that something bad might be coming down the pike. But at the time, the Post reported: “The health commission in Wuhan, a transit and business hub, says there is no clear evidence that the unidentified disease can be transmitted between humans, and no health-care … Read more

Myers, “China Created a Fail-Safe System to Track Contagions. It Failed.” New York Times, March 29, 2020.

After SARS, China established a system for tracking cases of dangerous infectious diseases as well as outbreaks of new diseases. This story helps explain why that system broke down with covid-19, with local leaders not wanting to displease the central Chinese government.